Old Web
English
Sign In
Acemap
>
authorDetail
>
Janice L. Cohen
Janice L. Cohen
University of Arizona
Medicine
Ovarian cancer
Oncology
Internal medicine
Immunology
4
Papers
74
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Investigation of bendamustine HCL in a Phase 2 study in women with resistant ovarian cancer
2013
Investigational New Drugs
Amanda F. Baker
Denise J. Roe
Cynthia Laughren
Janice L. Cohen
Heather M. Wright
Mary C. Clouser
Haiyan Cui
David S. Alberts
Setsuko K. Chambers
Show All
Source
Cite
Save
Citations (0)
debulked ovarian cancer
2012
Setsuko K. Chambers
Michael F. Janicek
Janiel M. Cragun
Kenneth D. Hatch
Haiyan Cui
Cynthia Laughren
Mary C. Clouser
Janice L. Cohen
Heather M. Wright
David S. Alberts
Show All
Source
Cite
Save
Citations (0)
Phase I Trial of Intraperitoneal Pemetrexed, Cisplatin, and Paclitaxel in Optimally Debulked Ovarian Cancer
2012
Clinical Cancer Research
Setsuko K. Chambers
H.-H. Sherry Chow
Michael F. Janicek
Janiel M. Cragun
Kenneth D. Hatch
Haiyan Cui
Cynthia Laughren
Mary C. Clouser
Janice L. Cohen
Heather M. Wright
Nisreen Abu Shahin
David S. Alberts
Show All
Source
Cite
Save
Citations (27)
Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer
2010
Clinical Cancer Research
Setsuko K. Chambers
Mary C. Clouser
Amanda F. Baker
Denise J. Roe
Haiyan Cui
Molly Brewer
Kenneth D. Hatch
Michael S. Gordon
Mike F. Janicek
Jeffrey D. Isaacs
Alan N. Gordon
Raymond B. Nagle
Heather M. Wright
Janice L. Cohen
David S. Alberts
Show All
Source
Cite
Save
Citations (47)
1